Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rheosorbilact vs Ringer's Lactate in Complex Therapy of Burns
NCT04152096Phase 4Completed
- Sponsor
- YURiA-PHARM
- Start
- Feb 2017
- Primary completion
- Sep 2020
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 4
01
Overview
Phase 4, randomised, single-blind trial of rheosorbilact in burn injury (2 arms), sponsored by YURiA-PHARM. Primary endpoint: Sequential Organ Failure Assessment Score at Day 3. Started Feb 2017; status: completed.
02
Drugs
rheosorbilact
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT04152096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04152096.